HomeBCART • EBR
add
Biocartis Group NV
Previous close
€0.29
Year range
€0.29 - €0.29
Market cap
27.18M EUR
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | 2023info | Y/Y change |
|---|---|---|
Revenue | 47.69M | -17.74% |
Operating expense | 35.98M | -2.32% |
Net income | 18.38M | 128.11% |
Net profit margin | 38.53 | 134.17% |
Earnings per share | — | — |
EBITDA | -36.39M | 13.27% |
Effective tax rate | -0.93% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 645.00K | -97.53% |
Total assets | 1.04M | -99.09% |
Total liabilities | 320.00K | -99.78% |
Total equity | 721.00K | — |
Shares outstanding | 93.92M | — |
Price to book | 29.00 | — |
Return on assets | -44.76% | — |
Return on capital | -55.63% | — |
Cash Flow
Net change in cash
| (EUR) | 2023info | Y/Y change |
|---|---|---|
Net income | 18.38M | 128.11% |
Cash from operations | -47.84M | -6.66% |
Cash from investing | -4.82M | 11.23% |
Cash from financing | 27.29M | 21.47% |
Net change in cash | -25.48M | 7.00% |
Free cash flow | -4.15M | 85.82% |
About
Founded
2007
Headquarters
Website
Employees
500
